Chapter

US Cohorts review: The HIV Outpatient Study (HOPS) and the Multicenter AIDS Cohort Study (MACS)

Frank J. Palella, Anne C. Moorman, John T. Brooks (HOPS), John Phair, Lisa Jacobson, Roger Detels, Joseph Margolick and Charles Rinaldo (MACS)

in A Decade of HAART

Published in print August 2008 | ISBN: 9780199225859
Published online September 2009 | e-ISBN: 9780191723834 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780199225859.003.0011
US Cohorts review: The HIV Outpatient Study (HOPS) and the Multicenter AIDS Cohort Study (MACS)

Show Summary Details

Preview

This chapter presents an overview of HIV Outpatient Study (HOPS) and Multicenter AIDS Cohort Study (MACS). HOPS is a prospective observational cohort study that was initiated in 1993 by the US Centers for Disease Control and Prevention (CDC), and is currently expected to continue collecting and analyzing longitudinal data on HIV-infected outpatients until mid-2011. It is the longest-running and only remaining US government-sponsored multi-site prospective cohort of a diverse spectrum of people living with HIV infection and receiving routine clinical care in the United States. MACS was funded in 1983 by the US National Institute of Allergy and Infectious Disease (NIAID), and recruitment of participants began in early 1984. The initial rationale for funding this epidemiological investigation was to collect specimens that could potentially be of use in identifying an infectious agent as the cause of AIDS and to delineate the natural history of pre-AIDS in men who have sex with men (MSM), the first epidemiologically identified group at high risk of developing the syndrome.

Keywords: cohort studies; HIV/AIDS; highly active antiretroviral therapy; HIV infection; HAART; infectious agent; MSM

Chapter.  6771 words.  Illustrated.

Subjects: Public Health and Epidemiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.